The global menopause treatment market involves products used for the treatment of symptoms associated with menopause such as hot flashes, mood swings, vaginal dryness, reduced sex drive and night sweats. Some of the commonly used menopause treatment products include hormone therapy, selective estrogen receptor modulators (SERMs), antidepressants, and OTC therapies. Hormone therapy is considered as one of the most effective treatments as it replaces hormones that are diminished during menopause. However, concerns over treatment safety have limited its usage. Key players are focusing on development of bioidentical hormone therapies, tissue selective estrogen complex (TSEC) and non-hormonal options to address the unmet needs.

The global menopause treatment market was valued US$ 15.33 Bn in 2023 and is expected to reach US$ 24.33 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
Key Takeaways

Key players operating in the Global Menopause Treatment market are Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck and Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter and Gamble, Duchesnay USA., TherapeuticsMD, Inc., and Amneal Pharmaceuticals LLC. The growing demand for effective treatment with minimum side effects is boosting research and development activities among key companies. Several key players are collaborating with biotech companies and research institutes to develop novel therapies. Technological advancements are also enabling development of therapies tailored as per individual needs and stage of menopause.

Market Trends

The increasing adoption of combination therapies that target symptoms simultaneously is one of the key trends in the global menopause treatment market. Combination of Global Menopause Treatment Market Trends with other therapies is gaining traction owing to superior efficacy. Another trend is rising preference for botanical/herbal supplements and bioidentical hormones over conventional hormone therapies due to perceived safety benefits.

Get More Insights on- Global Menopause Treatment Market

Explore More Related Article On-Nuclear Fusion Market